The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
Open accessAbstract
IntroductionGraft-versus-host disease (GVHD) is one of the major complications of allogeneic bone marrow transplantation and blood transfusion (1).GVHD is initiated by donor T cells specific against the host antigens (1-3).Acute GVHD is a rapidly progressing systemic illness characterized by immunosuppression and tissue injury in various organs, including liver, skin, and intestinal mucosa (1-7).Especially in the liver, GVHD is characterized by portal hepatitis, nonsuppurative destructive cholangitis (NSDC), cholestasis, and endotheliitis (1,2,8).Although the molecular pathogenesis of GVHD remains to be uncovered, there is general agreement that infiltrating T lymphocytes play a central role (3-5, 7, 9, 10).Previous studies have shown that in parent-into-F1 models, acute GVHD is characterized by a severe reduction in host lymphocytes and a profound immunodeficiency due to the activation of both donor CD4 + and CD8 + T cell subsets in response to host alloantigens (3, 11, 12).Early events that favor the development of acute GVHD are engraftment of CD8 + T cells and production of IFN-γ by donor CD4 + T cells (3, 12).However, these studies were carried out in the spleen, not in main target organs such as liver, skin, and intestine.In addition, recent studies suggest that both perforin-and Fas-mediated pathways are involved in the systemic signs of GVHD, and epithelial cell injury in liver, skin, and intestine appears to be Fas-mediated (4-6, 9, 10).These observations led us to investigate the main target organ, the liver, which has a pivotal role in maintaining homeostasis.Leukocyte migration is a multistep process involving the sequential activation of various adhesion molecules located on the immune cells and the vascular endothelium, as well as a vast array of chemo-kines and their receptors (13-17).The involvement of chemokines and their receptors in inflammation has been elucidated during the last several years (18-23), but their functional roles in the progression of various diseases are not yet fully understood.In light of the recruitment of alloreactive T lymphocytes to a specific tissue site in GVHD, we focused on the characterization of chemokine receptors on these key lymphocytes and investigated the role of these cells in the pathogenesis of liver injury in a murine GVHD model. MethodsAnimals.C57BL/6 mice (B6, H-2 b ) were used as donors, and (B6 × DBA/2)F1 mice (BDF1, H-2 b×d ) were used as
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709
A novel method for real time quantitative RT-PCR.
Gibson, U. E., Heid, C. A., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.995 · Cited by 2,075
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Ferrara, J. L. M., & Deeg, H. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241005 · Cited by 1,219
CCR5 is characteristic of Th1 lymphocytes
Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C., & Dayer, J.-M. (1998) · Nature · doi:10.1038/34814 · Cited by 866
Mig and IP-10: CXC chemokines that target lymphocytes
Farber, J. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.3.246 · Cited by 779
Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β
Taub, D. D., Conlon, K., Lloyd, A. R., Oppenheim, J. J., & Kelvin, D. J. (1993) · Science · doi:10.1126/science.7682337 · Cited by 730
Rollins, B. J. (1997) · PubMed · Cited by 603
Liu, Y., & Janeway, C. A. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1735 · Cited by 359
Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases
Gleichmann, E., Pals, S. T., Rolink, A. G., Radaszkiewicz, T., & Gleichmann, H. (1984) · Immunology Today · doi:10.1016/0167-5699(84)90126-9 · Cited by 342
Rottman, J. B., Ganley, K., Williams, K. C., Wu, L., Mackay, C. R., & Ringler, D. J. (1997) · Europe PMC (PubMed Central) · Cited by 316
Chemokine Receptors: Keys to AIDS Pathogenesis?
Littman, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81429-4 · Cited by 300
Braun, M. Y., Lowin, B., French, L., Acha-Orbea, H., & Tschopp, J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.657 · Cited by 297
Baker, M. B., Altman, N. H., Podack, E. R., & Levy, R. B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2645 · Cited by 281
Zhou, Y., Kurihara, T., Ryseck, R.-P., Yang, Y., Ryan, C., Loy, J., Warr, G., & Bravo, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.4018 · Cited by 245
Rus, V, Svetic, A., Nguyen, P., Gause, W. C., & Via, C. S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2396 · Cited by 222
Krenger, W., Snyder, K. M., Byon, J. C., Falzarano, G., & Ferrara, J. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.585 · Cited by 187
Yang, Y. G., Dey, B. R., Sergio, J. J., Pearson, D. A., & Sykes, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4992 · Cited by 179
Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice.
Yoneyama, H., Harada, A., Imai, T., Baba, M., Yoshie, O., Zhang, Y., Higashi, H., Murai, M., Asakura, H., & Matsushima, K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4619 · Cited by 141
Self-citationFowler, D. H., Kurasawa, K., Husebekk, A., Cohen, P. A., & Gress, R. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1004 · Cited by 134
IL-12 is a central mediator of acute graft-versus-host disease in mice
Williamson, E., Garside, P., Bradley, J. A., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.689 · Cited by 107
Shustov, A. R., Nguyen, P., Finkelman, F. D., Elkon, K. B., & Via, C. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2848 · Cited by 106
Su, S., Mukaida, N., Wang, J.-B., Nomura, H., & Matsushima, K. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.5.658 · Cited by 97
Self-citationNovelli, F., Pierro, F. D., di Celle, P. F., Bertini, S., Affaticati, P., Garotta, G., & Forni, G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.496 · Cited by 85
Williamson, E. M., Garside, P., Bradley, J. A., More, I. A. R., & Mowat, A. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1208 · Cited by 85
Saito, K., Sakurai, J., Ohata, J., Kohsaka, T., Hashimoto, H., Okumura, K., Abe, R., & Azuma, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4225 · Cited by 84
Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
Ellison, C. A., Fischer, J. M. M., HayGlass, K. T., & Gartner, J. G. (1998) · PubMed · Cited by 80
Novelli, F., D’Elios, M. M., Bernabei, P., Ozmen, L., Rigamonti, L., Almerigogna, F., Forni, G., & Prete, G. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.206 · Cited by 75
Murine Graft-Versus-Host Disease in an F1-Hybrid Model Using IFN-γ Gene Knockout Donors
Ellison, C. A., Fischer, J. M. M., HayGlass, K. T., & Gartner, J. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.631 · Cited by 68
Bobé, P., Bonardelle, D., REYNES, M., Godeau, F., Mahiou, J., Joulin, V., & Kiger, N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4197 · Cited by 26
Cited by
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Jia, H. P., Look, D. C., Shi, L., Hickey, M., Pewe, L., Netland, J., Farzan, M., Wohlford-Lenane, C., Perlman, S., & McCray, P. B. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14614-14621.2005 · Cited by 949
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Self-citationLymphoid Neogenesis in Rheumatoid Synovitis
Takemura, S., Braun, A., Crowson, C., Kurtin, P. J., Cofield, R. H., O’Fallon, W. M., Goronzy, J. J., & Weyand, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1072 · Cited by 660
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
Teshima, T., Ordemann, R., Reddy, P., Gagin, S., Liu, C., Cooke, K. R., & Ferrara, J. L. M. (2002) · Nature Medicine · doi:10.1038/nm0602-575 · Cited by 521
Metadata
- Authors
- Murai, M., Yoneyama, H., Harada, A., Yi, Z., Vestergaard, C., Guo, B., Suzuki, K., Asakura, H., & Matsushima, K.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-07-01
- Volume
- 104
- Issue
- 1
- Pages
- 49-57
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1964616348
- Cited by
- 301
- References
- 33
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.